Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

La Jolla Pharmaceutical Co (LJPC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow La Jolla Pharma's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
La Jolla Pharma historical data, for real-time data please try another search
6.220 0.000    0.00%
19/08 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 6.200 - 6.240
La Jolla Pharma 6.220 0.000 0.00%

La Jolla Pharmaceutical Co Company Profile

 
Get an in-depth profile of La Jolla Pharmaceutical Co, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

61

Equity Type

ORD

La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older. It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. Its product candidates that are in early stage clinical or preclinical development include TP-6076, an IV formulation of a fully synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria; TP-271, an IV and oral formulation of a fully synthetic fluorocycline for the treatment of respiratory disease caused by bacterial biothreat and antibiotic-resistant public health pathogens, as well as bacterial pathogens associated with community-acquired bacterial pneumonia; and TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia. La Jolla Pharmaceutical Company was incorporated in 1989 and is based in Waltham, Massachusetts. As of August 22, 2022, La Jolla Pharmaceutical Company operates as a subsidiary of Innoviva, Inc.

Contact Information

Address 201 Jones Road Suite 400
Waltham, 02451
United States
Phone 617 715 3600
Fax -
Web
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

LJPC Comments

Write your thoughts about La Jolla Pharmaceutical Co
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
stats con chris
stats con chris Oct 07, 2020 2:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
forecast is 10M? wow seems tough
SS SS
SS SS Jun 05, 2020 6:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
to entry or not to entry ? is it worth ?
SS SS
SS SS Jun 05, 2020 6:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
any opinion ?
stats con chris
stats con chris May 27, 2020 2:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why this -26?
Issa Atallah
Issa Atallah Feb 03, 2020 2:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it will reach 20 within 2 months
stats con chris
stats con chris Dec 04, 2019 8:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lucky i bought at 2.6.. too good to be true
stats con chris
stats con chris Nov 25, 2019 9:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow. bad day ...bad week nad year... game over
stats con chris
stats con chris Nov 13, 2019 9:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
oh no. Jolla dont die
Issa Atallah
Issa Atallah Jun 10, 2019 9:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it will hit 14 to 16 during this week
RJ III
RJ III Jun 08, 2019 10:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Can you give more details about the company's business?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email